Market Research Blog

According to a recent study by Future Market Insights (FMI), the global intraosseous (IO) infusion devices is expected to witness high growth during the forecast period. The market is expected to grow from US$ 3.8 Bn in 2021 to over US$ 7.9 Bn by 2031. It will therefore register CAGR of around 7.6% over the forecast period (2021-2031).

According to a recent study by Future Market Insights (FMI), the GCC medical gloves market is reached US$ 145 Mn in 2020. With sales growing at a healthy 7.9% CAGR, the market valuation is set to reach US$ 343 Mn by 2031.

Global hypercalcemia treatment market revenues are anticipated to reach US$ 9.64 Bn in 2017, up from US$ 7.86 Bn in 2015. Increasing prevalence of hyperparathyroidism-related hypercalcemia and rising incidence of multiple myeloma are major factors expected to fuel growth of the global hypercalcemia treatment market over the forecast period. Availability of drug therapy alternatives over surgeries and favourable reimbursement policies are key factors expected to fuel global market growth.

Visualisation in medical diagnosis is vital to detect diseases and to decide the healing technique. Endoscopes have been used since ages, however, chip-on-the-tip endoscopes have put foot in the endoscopes market and revolutionized the technique to endoscopy. Chip-on-the-tip endoscopes is a handheld miniature device with camera, as the name suggests, situated at the tip of the chip-on-the-endoscope. These cameras produce a high-dimensional image with greater pixel quality and sharpness to aid precise visualization of the structures inside the body. Chip-on-the-tip endoscopes allow minimally invasive surgeries with least opening in the body and good resolution video on the screen to assist the surgeon during surgery. Advance technology in microelectronics as well as compact image sensors have made chip-on-the-tip endoscopes feasible. Chip-on-the-tip endoscopes allow quick diagnosis compared to any other endoscopic instrument and enable visualisation of very fine structures through high quality image. Chip-on-the-tip endoscopes are also called as flexible endoscopes as they do not need to be adjusted, aligned or focussed unlike fibre-optic endoscopes. Adding to the list of advantages of chip-on-the-tip endoscopes are the compact design, biocompatible integration and cost-efficient and long-life.

Get a Free Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-7994

Chip-on-the-Tip Endoscopes: Market Dynamics

The key factors contributing to the growth of the global chip-on-the-tip endoscopes market include rising adoption of chip-on-the-tip endoscopes for diagnostic applications, increasing application in minimally invasive surgeries. Availability of high-resolution and high-dimensional visualization equipment such as camera lens and HD-screens also propel the demand for chip-on-the-tip endoscopes. The rising awareness about minimally invasive surgeries and better patient outcome also contribute to the expansion of chip-on-the-tip endoscope market. Precise navigation and visualization which is essential in microsurgeries at complex structures is attained with the chip-on-the-tip endoscope future fueling the market. The expensive nature of the device can be considered as a restraint for adoption of the endoscopes.

Chip-on-the-Tip Endoscopes: Overview

Exponential growth in the chip-on-the-tip endoscope market is estimated due to increasing technological advances in high-dimensional real-time visualization technology. The expansion of the concerned market is also largely dependent on the increasing number of endoscopic and minimally invasive surgeries performed. Based on the product type, chip-on-the-tip endoscopes market has been segmented into rhinoscopes, laryngoscopes, bronchoscopes, gastroscopes, colonoscopies, arthroscopes, ureteroscope and others. Single-use segment holds a maximum share of global chip-on-the-tip endoscopes market on the basis of usage. The end users of the device are segmented as hospitals, diagnostic/imaging centers, ambulatory surgical centres, endoscopy facilities and clinics.

Chip-on-the-Tip Endoscopes: Region-wise Outlook

On the basis of geography, the global chip-on-the-tip endoscope market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa.The North America market holds the largest revenue share, rising adoption of the chip-on-the-tip endoscopes for diagnostic applications as well as endoscopic surgeries and high healthcare expenditure in North America. Europe accounts for the second large revenue share in the global chip-on-the-tip endoscopes market, owing to increasing adoption of the device, presence of many manufactures and improved healthcare facilities. Asia Pacific is predicted to witness rapid growth, owing to increasing technological advances are presence of local manufacturers.  China is expected to register significant growth, owing to numerous players in the market and adoption of latest technology by the end users. Latin America and Middle East & Africa are projected to exhibit slow growth in chip-on-the-tip endoscopes market, owing to the high cost nature of the product.

Request Report Methodology: https://www.futuremarketinsights.com/askus/rep-gb-7994

Chip-on-the-Tip Endoscopes: Key Players

Examples of some of the key players present in the global chip-on-the-tip endoscopes market are Olympus Europa SE & Co. KG, Fujifilm, Serwell Medi Equip (P) Ltd, HOYA Corporation, Physik Instrumente (PI) GmbH & Co. KG, JEDMED, Amico Group, Happersberger otopront GmbH, Karl Storz SE & Co. KG, Ambu A/S, TOSHIBA CORPORATION, LLT MEDICAL, OmniVision Technologies, Inc., Boston Scientific Corporation among others.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-7994

Chip-on-the-Tip Endoscopes: Segmentation

The global Chip-on-the-Tip Endoscopes market is segmented on basis of product type, application, end user and geography.

A new study of Future Market Insights (FMI) indicates that the global general anesthesia drugs market is poised for steady growth in the years ahead. Today, the general anesthesia drugs market remains driven by increased proportion of elderly patients and rising volume of surgical procedures; FMI analyst forecasts the market to witness 3.5% CAGR during the period, 2019-2029.

Microplate washers are used to remove reagents from sample wells such that they can be prepared for the next process. The microplate washer dispenses wash solution into the sample wells. This is done through a series of cycles of buffer dispense and aspiration. Microplate washer follows a series of cycles to ensure that any unbound liquid is thoroughly removed and other bound substances are left within the microplate wells. The microplate washer then removes the wash solution through suction.

The microplate washer is composed of a microplate work station that includes a priming tray, reservoir kit, pump module and aspiration head used for dispensing the wash solution. These microplate washers are available as automates and manual microplate washers. The manual microplate washers are designed such that they can be completely controlled by its operator, from filling the reservoir to aspiration. For the manual type of microplate the lab technician or researcher prepares a script for the timing of the activities such as dispensing, waiting, shaking and aspiration. Once the script is prepared the microplate is inserted into the microplate washer for processing. The automatic microplate washer is designed such that it can profile the microplates automatically thereby reducing human errors. The automatic microplate washers can read and interpret the size of the microplate. Some microplate washers require hardware attachments for different types of microplates. Automatic and manual microplate washers are available in two configurations, i.e., plate and strip. The plate type of microplate washer cleanses the whole microplate in a single process, while the strip type of microplate washer cleanses the microplate strip by strip.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-7518

Microplate washers can be used for a number of applications including cell cultures, protein assays, western blots and beads, Enzym-linked immunosorbent assay (ELISA), as well as for DNA purification processes. The microplate washers available in the market are compatible with microplates up to 384 wells. Up to 5 wash solutions or buffers can be dispensed or attached to the microplate washer and can dispense a range of volumes from 10 microliters to 3 milliliters.

Microplate Washer Market: Drivers and Restraints

The microplate washers market is expected to witness significant growth in the near future owing to increase in number of drug discovery research centers and clinical diagnostics, and high throughput screening application. Other factors that are expected to drive the growth of the market are increased research funding in the biotech & pharmaceutical industry along with the increasing number of service providers through private labs.

Microplate Washer Market: Overview

The global microplate washer market is expected to gain significant growth rate over the forecast period. The demand for microplate washers is expected to gain traction over the forecast period due to increasing research in the biotechnology & pharmaceutical industries. The increasing number of private labs for research & similar services is also adding to the increased demand for the product worldwide.

Request Brochure of Report: https://www.futuremarketinsights.com/reports/brochure/rep-gb-7518

Microplate Washer Market: Regional Outlook

In terms of geography, the global microplate washer market is segmented into North America, Eastern Europe, Western Europe, and Asia- Pacific excluding China & Japan (APECJ), China, Japan, Middle-East & Africa and Latin America. North America is expected to be the dominant regional market for microplate washers due to the rise in per capita expenditure on healthcare and technological advancement. Germany, France, and the U.K. are expected to the key contributing courtiers in the Western Europe market for microplate washers. The Asia Pacific excluding China and Japan microplate washer market is expected to witness significant growth over the forecast period due to availability of low-cost products in the region. China is expected to be one of the major revenue contributing countries in the global microplate washer market due to the availability of cost-effective microplate washers increased healthcare funding in the region.

Microplate Washer Market: Key Participants

Example of some key participants in the global microplate washer market are BioTek Instruments, Molecular Devices LLC, BD Biosciences, Bio-Rad, Calbiotech, Inc, Hudson Robotics, Inc, Tecan Trading AG, Thermo Fisher Scientific, and Titertek-Berthold, among others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-7518

Microplate Washer Market: Segmentation

Injectable drug delivery is the mode of introduction of a drug directly into the bloodstream of a patient. Drugs are directly injected into the bloodstream of patients, owing to which they need to be sterile. Sterile injectable drugs are usually available in liquid form. Sterile injectable drugs are usually permit to transport directly into blood stream sometimes. The manufacturing of sterile injectable drugs is a complex process and recurs high initial investment and operating cost. Major factor that is increasing the demand for sterile injectable is increasing number of cancer cases. According to the World Cancer Research Fund International (WCRFI), around 14.1 million cancer cases were accounted worldwide in 2012. As per the WCRFI, till 2035, the number is expected to reach 24 million. Small molecule monoclonal antibodies are used for cancer treatment therapy. Cancer therapies are the import engine of the growth of the sterile oncology injectable market.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-6604

Focus of the Manufacturers on Technologies, Materials and Robust Manufacturing Process

The supply of drugs is short in the U.S., with some shortage continuing for multiple years. The majority of these drugs are generic sterile injectable products. Companies are focusing on increase in supply of sterile oncology injectable. Manufactures are now focusing on superior technology and procurement of higher grade raw materials. Contract manufacturing organization can help to address drug shortage problem in North America and Europe. They adopt new technologies and rapidly transfer in sterile injectable manufacturing processes.

Sterile Oncology Injectable Market Assessment by Product Type

Dynamics of the Sterile Oncology Injectable Market

The global sterile oncology injectable market is projected witness significant growth over the forecast period due to rising prevalence of cancer globally. Increase in investment by drug manufactures in the development of sterile oncology injectable, short time frame for approval of new drug in cancer treatment are some of the key factor boosting demand for sterile oncology injectable market globally. Rapid FDA approvals of sterile oncology injectable along with shortened approval times for drug development in cancer care is helping manufacturers to accelerate drug supplies. These factors are eventually boosting the growth of the global sterile oncology injectable market. However, stringent rules and regulations in manufacture of sterile oncology injectable and high quality and care required in manufacturing, challenges in storage, packaging and distribution of oncological sterile injectable are likely to hamper the growth of sterile oncology injectable market. Also, sterile drugs require complex equipment for manufacturing.

Request Brochure of Report: https://www.futuremarketinsights.com/reports/brochure/rep-gb-6604

Market Expansion Due to Agreements and Partnerships

Sterile oncology injectable manufacturers are focusing on partnership and geographical expansion in different countries to establish facilities in various regions. Pfizer has expanded its oncology portfolio with acquisition of Hospira. Hospira has a broad sterile injectable product line, which includes acute care and oncology injectable. Baxter also acquired India-based injectable firm Claris Injectable Limited and expanded its portfolio in anti-infective, analgesics and critical care and oncology injectable.

Regional Market Outlook

North America will continue to dominate the global market due to the availability of advanced technologies and more number of clinical trial, surge in demand for innovative medical technology in the U.S. According to the National Institute of Cancer in 2016, around 1,685,210 new cancer cases are likely to be diagnosed in the U.S. Europe is expected to hold second large market share in global sterile oncology injectable market due to growing prevalence of chronic diseases. Competition from low-cost pharmaceutical manufacturing countries such as India and China has led to discontinuation of many products. Asia Pacific is expected to exhibit attractive market share owing to increase in health awareness and demand for advanced medical technology in oncology treatment and increasing investments on low-cost pharmaceutical manufacturing.

Competition Outlook

Examples of some of the key players identified in the global sterile oncology injectable market are Eli Lilly & Company, Biocon Ltd, Baxter International Inc., Hikma Pharmaceuticals PLC, Mylan N.V., Sandoz International GmbH, Teva Pharmaceuticals Industries Ltd, and Pfizer Inc., among others. Sterile oncology injectable are used for cancer treatment and therapies. Recent M&A activities have fueled the growth prospect for sterile oncology injectable. Recent deal of US$ 17 Billion between Pfizer & Hospira provides platform for growth for Pfizer’s Global Established Pharmaceutical (GEP) business. Hospira’s generic sterile injectable products, including acute care and oncology injectable have provided boost to Pfizer’s sterile injectable offerings in oncology market. However, preference of large molecules offers a global opportunity to its manufacturers, as these are the common molecules recently used globally for oncology application.

Sterile CMOs:

• Catalent Pharma Solutions
• Baxter
• Akorn
• Althea
• Vetter
• Piramal Pharma Solutions (ColdStream Laboratories)
• IDT Biologica.

Medium Scale Manufacturers/Providers:

• Biocon Ltd
• Baxter International Inc.
• Hikma Pharmaceuticals PLC
• Sandoz International GmbH

Large Scale Manufacturers/Providers:

• Mylan N.V
• Teva Pharmaceuticals Industries Ltd
• Pfizer Inc.
• Eli Lilly & Company

Key Data Points Covered in Report

The report covers exhaustive analysis on:

• Sterile Oncology Injectable Market by molecule type, distribution channel, indication and region
• Regional level market analysis of North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding China & Japan, China, Japan, Middle East & Africa by molecule type, distribution channel, indication segments and country
• Sterile Oncology Injectable Market Dynamics & Opportunity Assessment
• Historical Actual Market Size, 2013 – 2017
• Sterile Oncology Injectable Market Size & Forecast 2018-2028
• Sterile Oncology Injectable Market Current Trends/Issues/Challenges
• Competition & Companies involved

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-6604

Market Segmentation

By Molecule Type

Surgical broaches are simple instruments designed to provide reconstructive and supportive approach in comforting the operative target in surgical procedures. Surgical broaches are similar to rasps as they are used provide a fine edges to support replacement implants. Surgical broaches are used to form an intramedullary canal in a bone to provide prosthetic support. The presence of cutting teeth provide an efficient approach for guiding such implant and provides a suitable gap between the prosthesis and the intramedullary canal. With better technological developments it has led to a 3D surface textures for better removal of bone particles. Generally made of biocompatible metal to provide a strong and sturdy approach in the operation which requires the removal of bone to place an implant, the features result to create sharp points needed to efficiently place prosthetic. The surgical broaches requires to be of high strength in order to come up with the best result during an operation providing accurate and uniform alignment between implants

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-7147

Surgical broaches Market: Drivers and Restraints

Primary factors driving surgical broaches market include growing need for replacement surgeries. Advancement in the production of surgical broaches like 3D etching process which makes it rather convenient as an instrument to use in general orthopedic surgeries. It is an important instrument used in total hip replacement, and with rise in geriatric population. Besides, surgical broaches could also be used in removing soft medial cancellous bone, pulse lavage the canal. However, alternative approaches like rasps which operates the same limit the growth of the global surgical broaches market. Implants now have a set broach to make their own canal for perfect fitting will affect the already established surgical broaches market. The market is also dependent on the trauma incidences which reports the use of surgical broaches as Musculoskeletal injuries in developing countries account for a substantial share (13%) in global burden for trauma cases. Though, state wise medical device regulations makes it harder for the product to penetrate unmet markets. Much of the manufacturers are doing it regionally but it slows down the process in order to make efficient product. Different healthcare regulations or standards are followed by respective regions for the use surgical broaches.

Surgical broaches Market: Overview

The global market for surgical broaches is highly consolidated with very few players operating in the global space. Combined approaches of using surgical broaches with other surgical instruments to obtain accurate results to treat patients, which is expected to create high demand for surgical broaches in invasive bone related surgeries. Some of the established brands of surgical broaches are, Zimmer Biomet, Tecomet Inc, Smith and Nephew, Sandvik and others.

Surgical broaches Market: Regional Wise Outlook

Geographically, the global surgical broaches market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to be the leader in global surgical broaches market owing to the quality difference healthcare infrastructure. The Surgical broaches market in Asia Pacific excluding Japan is expected to grow due to expansion of major manufacturers into such fragmented markets. Europe is expected to take a large share in the global surgical broaches market during the forecast period because of their medical expenditure over healthcare supporting such use.

Request Report Methodology: https://www.futuremarketinsights.com/askus/rep-gb-7147

Surgical broaches Market: Key Players

Examples of some of the major players in the global Surgical broaches market are Surgical broaches are Integrated Medical Technologies (IMT) USA LLC, Zimmer Biomet, Tecomet Inc, Smith and Nephew, Sandvik A, Precision Edge Surgical and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-7147

Surgical broaches Market: Segmentation

Tentatively, the global surgical broaches Market has been segmented on the basis of application, end users, and geography.

Automated blood processing equipment is used for the blood collection and processing of whole blood sample. The primary use of whole blood is as a source material for the preparation of blood components such as RBC (red blood cells), WBC (White blood cells), platelets, plasma and others components. The automated blood processing equipment helps to convert whole blood into different blood components, which are mostly used for the blood transfusion and others purposes. Reduced human intervention with minimal contamination chances and shorten the duration of blood processing by reducing processing steps are the key benefits of the automated blood processing equipment. Hospitals and blood banks focus on to optimize throughput without increasing lab burden, expedite patient care and enhance laboratory efficiency through automated blood processing equipment. Automated blood processing equipment provides efficient outcomes, which facilitate diagnosis and treatment, reduce emergency room times with faster and reliable results than the traditional blood processing equipment.

Get a Free Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-6712

Technology Advancement

Blood transfusion procedure can be helpful in various life-threating situations such as an accident or surgery, cancer therapy and disease (leukemia, myeloma, etc.). Manual collection and processing of whole blood should be carried out taking safety measures, but that would be time-consuming and contamination prone process. The main advantage of automated blood processing equipment include reduction of a number of equipment involved in blood component separation processing, overcome the laborious steps and standardize the quality of blood component. Healthcare facilities are more interested in automated blood processing equipment due to compact characteristics that lead to the reduction of workspace and increases production efficiency.

Factors Driving the Automated Blood Processing Equipment Market

Rise in demand of safe and enhanced quality of blood components, increasing incidence of chronic diseases, strong campaigning for blood donation programs and growing healthcare spending are the key factors that drive the market growth over the forecast period. Technological advancements and development in donation screening test kits also play a vital role in the increasing demand for automated blood processing equipment. Changes in blood collection procedure and gradual migration of manual blood processing to automated processing machine are all poised to benefit the market growth. Also, the top manufacturers in the market are expanding the value chain to forward integrate the market in developing economies. In most of the developed countries, increasing investment in terms of healthcare spending and investment in healthcare facilities by government authorities are impelling the demand for automated blood processing equipment.

Request Brochure of Report: https://www.futuremarketinsights.com/reports/brochure/rep-gb-6712

Regional Market Outlook

North America leads the automated blood processing equipment market owing to developed healthcare infrastructure, support from the government, and availability of advanced blood collection facilities. Western Europe is the second leading market for automated blood processing equipment due to increasing blood donation centers and blood transfusion sites that propel the demand. Increase in chronic diseases and surgical procedural volumes are also the leading factors that have raised the demand for pathogen-free blood and its components, which further increase the demand for automated blood processing equipment. The Asia Pacific excluding China and Japan market is also expected to grow at a higher rate owing to improving healthcare spending on capital equipment for enhancing automation in facilities and large target patient pool.

Competition Outlook

Some of the players identified in the global automated blood processing equipment market are Beckman Coulter, Inc, Fresenius Kabi AG, Terumo Corporation, Immucor, Macopharma., Grifol, and Others. The companies are focusing on innovating their automated blood processing equipment in order to reduce their manufacturing costs and compete in the market with reduced prices. Companies are opting for mergers and acquisitions as their growth strategy for expanding their geographic presence.

Small-Scale Manufacturers/Providers

• Immucor
• JMS Singapore Pte Ltd
• MOELCA
• LMB Technologie GmbH
• Delcon SRL.

Medium-Scale Manufacturers/Providers

• Baxter Healthcare
• Macopharma
• Grifols

Large-Scale Manufacturers/Providers

• Beckman Coulter, Inc
• Fresenius Kabi AG
• Terumo Corporation

Key Data Points Covered in the Report

The report covers exhaustive analysis on:

• Automated Blood Processing Equipment Market by product type, end-user and region
• Regional level market analysis of North America, Latin America, Western Europe, Asia Pacific Excluding China & Japan, Japan, Middle East & Africa by product type, end-use segments and country
• Automated Blood Processing Equipment Market Dynamics & Opportunity Assessment
• Historical Actual Market Size, 2013 – 2017
• Automated Blood Processing Equipment Market Size & Forecast 2018-2028
• Automated Blood Processing Equipment Market Current Trends/Issues/Challenges
• Competition & Companies involved

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-6712

Market Segmentation